000 | 01915 a2200613 4500 | ||
---|---|---|---|
005 | 20250517133007.0 | ||
264 | 0 | _c20170529 | |
008 | 201705s 0 0 eng d | ||
022 | _a1526-632X | ||
024 | 7 |
_a10.1212/WNL.0000000000003586 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aDo, Le-Duy | |
245 | 0 | 0 |
_aCharacteristics in limbic encephalitis with anti-adenylate kinase 5 autoantibodies. _h[electronic resource] |
260 |
_bNeurology _c02 2017 |
||
300 |
_a514-524 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAdenylate Kinase _ximmunology |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAutoantibodies _xblood |
650 | 0 | 4 |
_aBiomarkers _xblood |
650 | 0 | 4 |
_aBrain _xdiagnostic imaging |
650 | 0 | 4 | _aDiagnosis, Differential |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHEK293 Cells |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunotherapy |
650 | 0 | 4 |
_aLimbic Encephalitis _xdiagnosis |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aNeurons _xpathology |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aChanson, Eve | |
700 | 1 | _aDesestret, Virginie | |
700 | 1 | _aJoubert, Bastien | |
700 | 1 | _aDucray, François | |
700 | 1 | _aBrugière, Sabine | |
700 | 1 | _aCouté, Yohann | |
700 | 1 | _aFormaglio, Maité | |
700 | 1 | _aRogemond, Veronique | |
700 | 1 | _aThomas-Antérion, Catherine | |
700 | 1 | _aBorrega, Laura | |
700 | 1 | _aLaurens, Brice | |
700 | 1 | _aTison, Francois | |
700 | 1 | _aCurot, Jonathan | |
700 | 1 | _aDe Brouker, Thomas | |
700 | 1 | _aLebrun-Frenay, Christine | |
700 | 1 | _aDelattre, Jean-Yves | |
700 | 1 | _aAntoine, Jean-Christophe | |
700 | 1 | _aHonnorat, Jerome | |
773 | 0 |
_tNeurology _gvol. 88 _gno. 6 _gp. 514-524 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1212/WNL.0000000000003586 _zAvailable from publisher's website |
999 |
_c26761435 _d26761435 |